Zobrazeno 1 - 10
of 29
pro vyhledávání: '"14(3)"'
Publikováno v:
Angewandte Chemie. 131:11792-11795
The first examples of rare-earth polyiodates, namely, REI5 O14 (RE=Y and Gd), have been prepared by hydrothermal reactions of RE2 O3 and H5 IO6 in H3 PO4 (≥85 wt % in H2 O), with extremely high yields (>95 %). They crystalize in the polar space gro
Autor:
C. C. Mackay, E. Clar
Publikováno v:
Chemischer Informationsdienst. 4
Publikováno v:
Experimental Physiology. 95:282-295
The regulation of blood pressure and sympathetic outflow by the brain renin–angiotensin system in animals subjected to raised or lowered dietary Na+ intake is unclear. This study compared the mean arterial pressure (MAP) and renal sympathetic nerve
Autor:
Wouter Dercksen, Dinja T. Kruger, Agnes Jager, Inge R. H. M. Konings, John W.M. Martens, Maurice P.H.M. Jansen, Jamal Oulad Hadj, Stefan Sleijfer, Epie Boven
Publikováno v:
Molecular Oncology, Vol 14, Iss 3, Pp 490-503 (2020)
Molecular Oncology, 14, 490-503. John Wiley & Sons Ltd.
Kruger, D T, Jansen, M P H M, Konings, I R H M, Dercksen, W M, Jager, A, Oulad Hadj, J, Sleijfer, S, Martens, J W M & Boven, E 2020, ' High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2-postmenopausal breast cancer patients treated with everolimus and exemestane ', Molecular oncology, vol. 14, no. 3, pp. 490-503 . https://doi.org/10.1002/1878-0261.12617
Molecular Oncology
Molecular oncology, 14(3), 490-503. Elsevier
Molecular Oncology, 14, 490-503. John Wiley & Sons Ltd.
Kruger, D T, Jansen, M P H M, Konings, I R H M, Dercksen, W M, Jager, A, Oulad Hadj, J, Sleijfer, S, Martens, J W M & Boven, E 2020, ' High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2-postmenopausal breast cancer patients treated with everolimus and exemestane ', Molecular oncology, vol. 14, no. 3, pp. 490-503 . https://doi.org/10.1002/1878-0261.12617
Molecular Oncology
Molecular oncology, 14(3), 490-503. Elsevier
We determined whether progression-free survival (PFS) in metastatic breast cancer (MBC) patients receiving everolimus plus exemestane (EVE/EXE) varies depending on circulating tumour DNA (ctDNA) characteristics. Baseline plasma cell-free DNA (cfDNA)
Autor:
Paul van der Leest, Ed Schuuring
Publikováno v:
Molecular oncology, 14(3), 487-489. Wiley
Molecular Oncology
Molecular Oncology, Vol 14, Iss 3, Pp 487-489 (2020)
Molecular Oncology
Molecular Oncology, Vol 14, Iss 3, Pp 487-489 (2020)
We determined whether progression‐free survival (PFS) in metastatic breast cancer (MBC) patients receiving everolimus plus exemestane (EVE/EXE) varies depending on circulating tumour DNA (ctDNA) characteristics. Baseline plasma cell‐free DNA (cfD
Publikováno v:
Ultrasound in Obstetrics & Gynecology. 48:650-655
OBJECTIVE To assess the accuracy of three-dimensional (3D) transvaginal sonographic (TVS) parameters in predicting the evolution of a pregnancy of unknown location (PUL). METHODS This was a prospective observational study performed at the early pregn
Publikováno v:
Ultrasound in Obstetrics & Gynecology. 50:632-634
Objective To report the outcome of dichorionic (DC) triplet pregnancies reduced to DC twins by laser ablation of the pelvic vessels of one of the monochorionic (MC) twins. Methods Intrafetal laser embryo reduction (ER) from DC triplets to DC twins wa
Autor:
Hongping Deng, Qingyan Zhao, Zongwen Guo, Xiaozhan Wang, Jinping Xiao, Zixuan Dai, Peixing Wan, Xule Wang, Congxin Huang
Publikováno v:
Pacing and Clinical Electrophysiology. 37:1357-1366
Background Heart failure (HF) and atrial fibrillation (AF) are associated with sympathetic activation. Renal sympathetic denervation (RSD) can suppress AF vulnerability. The impact of RSD on atrial electrophysiology in experimental HF is unclear. Met
Autor:
Dan Gutfinger, Neal L. Eigler, Michael Benser, Ian G. Crozier, Richard W. Troughton, Iain C. Melton, W.Y. Wandy Chan M.D., Andreas Blomqvist, Kjell Noren
Publikováno v:
Pacing and Clinical Electrophysiology. 37:810-819
Background We hypothesized that left atrial pressure (LAP) obtained by a permanent implantable sensor is sensitive to changes in cardiac resynchronization therapy (CRT) settings and could guide CRT optimization to improve the response rate. We invest
Autor:
Apostolos Tzikas, John L. Bass, Juan Ramirez, Marcela Alburquenque, Reda Ibrahim, Daniel Velasco-Sanchez, Joaquim Miró, Xavier Freixa, Daniel Aguirre, Paul Khairy
Publikováno v:
Catheterization and Cardiovascular Interventions. 83:571-580
Objectives To describe the initial world experience and mid-term follow-up of perimembranous ventricular septal defect (pmVSD) closure with a newly designed occluder. Background Transcatheter closure of pmVSDs has been associated with a substantial r